114 related articles for article (PubMed ID: 32301894)
1. Effect of Chinese herbal medicine on serum lipids in postmenopausal women with mild dyslipidemia: a randomized, placebo-controlled clinical trial.
Nie G; Yang H; Liu J; Cao X; Cheng F; Du Q; Wang X
Menopause; 2020 Jul; 27(7):801-807. PubMed ID: 32301894
[TBL] [Abstract][Full Text] [Related]
2. [Lipid profile comparison between pre- and post-menopausal women].
Wang N; Qin MZ; Cui J
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):799-804. PubMed ID: 27667280
[No Abstract] [Full Text] [Related]
3. Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.
Binder EF; Williams DB; Schechtman KB; Jeffe DB; Kohrt WM
Ann Intern Med; 2001 May; 134(9 Pt 1):754-60. PubMed ID: 11329233
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo controlled trial of an innovative herbal formula in the prevention of atherosclerosis in postmenopausal women with borderline hypercholesterolemia.
Kwok T; Leung PC; Lam C; Ho S; Wong CK; Cheng KF; Chook P
Complement Ther Med; 2014 Jun; 22(3):473-80. PubMed ID: 24906587
[TBL] [Abstract][Full Text] [Related]
5. Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial.
Vigna GB; Pansini F; Bonaccorsi G; Albertazzi P; Donegà P; Zanotti L; De Aloysio D; Mollica G; Fellin R
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):315-22. PubMed ID: 11302006
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between abdominal obesity and dyslipidemia in postmenopausal women in a community of Suzhou City in 2014].
Pang X; Yu L; Zhou H; Lei T; Chen G; Qin L
Wei Sheng Yan Jiu; 2017 Sep; 46(5):729-748. PubMed ID: 29903298
[TBL] [Abstract][Full Text] [Related]
7. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
Ho SC; Chen YM; Ho SS; Woo JL
Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.
Upadya H; Prabhu S; Prasad A; Subramanian D; Gupta S; Goel A
BMC Complement Altern Med; 2019 Jan; 19(1):27. PubMed ID: 30670010
[TBL] [Abstract][Full Text] [Related]
10. Rhus coriaria L. increases serum apolipoprotein-A1 and high-density lipoprotein cholesterol levels: a double-blind placebo-controlled randomized clinical trial.
Hajmohammadi Z; Heydari M; Nimrouzi M; Faridi P; Zibaeenezhad MJ; Omrani GR; Shams M
J Integr Med; 2018 Jan; 16(1):45-50. PubMed ID: 29397092
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
Dai L; Zhong LL; Cao Y; Chen W; Cheng Y; Lin XF; Bian ZX; Lu AP
Trials; 2016 Jun; 17(1):291. PubMed ID: 27316679
[TBL] [Abstract][Full Text] [Related]
12. Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.
Cai Y; Xing G; Shen T; Zhang S; Rao J; Shi R
Lipids Health Dis; 2017 Dec; 16(1):251. PubMed ID: 29273027
[TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.
Bone HG; Kiel DP; Lindsay RS; Lewiecki EM; Bolognese MA; Leary ET; Lowe W; McClung MR
J Clin Endocrinol Metab; 2007 Dec; 92(12):4671-7. PubMed ID: 17726081
[TBL] [Abstract][Full Text] [Related]
14. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women.
Wang CC; Cheng KF; Lo WM; Law C; Li L; Leung PC; Chung TK; Haines CJ
Menopause; 2013 Feb; 20(2):223-31. PubMed ID: 22990757
[TBL] [Abstract][Full Text] [Related]
16. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.
Yamamoto A; Horibe H; Mabuchi H; Kita T; Matsuzawa Y; Saito Y; Nakaya N; Fujioka T; Tenba H; Kawaguchi A; Nakamura H; Goto Y
Atherosclerosis; 1999 Mar; 143(1):55-73. PubMed ID: 10208480
[TBL] [Abstract][Full Text] [Related]
17. The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: A randomized controlled trial.
Muñoz-Aguirre P; Flores M; Macias N; Quezada AD; Denova-Gutiérrez E; Salmerón J
Clin Nutr; 2015 Oct; 34(5):799-804. PubMed ID: 25453396
[TBL] [Abstract][Full Text] [Related]
18. Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia - A Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
Yokote K; Niwa K; Hakoda T; Oh F; Kajimoto Y; Fukui T; Kim H; Noda Y; Lundström T; Yajima T
Circ J; 2020 May; 84(6):994-1003. PubMed ID: 32281579
[TBL] [Abstract][Full Text] [Related]
19. Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes.
Okamura S; Sawada Y; Satoh T; Sakamoto H; Saito Y; Sumino H; Takizawa T; Kogure T; Chaichantipyuth C; Higuchi Y; Ishikawa T; Sakamaki T
Tohoku J Exp Med; 2008 Dec; 216(4):341-51. PubMed ID: 19060449
[TBL] [Abstract][Full Text] [Related]
20. The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Cufer T; Lobelle JP; Mattiaci MR; Piccart M; Paridaens R
Ann Oncol; 2004 Feb; 15(2):211-7. PubMed ID: 14760111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
